Globe Scientific Introduces New Enhanced & Portable Clinical Centrifuges
By LabMedica International staff writers Posted on 03 Aug 2022 |
Globe Scientific, Inc. (Mahwah, NJ, USA) has introduced two new centrifuges to expand on its successful range of benchtop laboratory equipment. The expansion adds a new GCC-P portable clinical centrifuge as well as a new GCC-E50 which allows for spins of 50mL centrifuge tubes at an economical cost.
The GCC-P portable clinical centrifuge is designed for easy transport to facilitate convenient field separations using the included 12VDC car power adapter. It is compact in size and packed with the features required for routine clinical applications. The included six-position rotor accommodates 1.5mL to 5mL, 7mL, 10mL and 15mL tubes (all adapters are included). A weighted base ensures the unit remains stable in field environments. An easy-to-read LCD display shows both time and speed or RCF. Two program buttons enable simple programming and recall of regularly used methods. The timer will not count down until the set speed is reached to ensure your separations and experiments work as intended. Safety is maintained by an automatic lid lock that only disengages when the program is completed or manually once the unit has completely stopped.
Globe Scientific’s GCC-E50 enhanced clinical centrifuge is an economical solution for 15mL and 50mL separations with an enhanced user interface, easy to read backlit LCD display, tight accuracy, and automated self-diagnostics on startup. An extension based on the company’s GCC-E enhanced clinical centrifuge, the GCC-E50 employs a new rotor for spinning up to six 50mL centrifuge tubes or six 15mL centrifuge tubes.
Related Links:
Globe Scientific, Inc.
Latest Molecular Diagnostics News
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders
- Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access
- Respiratory and Throat Infection PCR Test Detects Multiple Pathogens with Overlapping Symptoms
- Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis
- First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety